Table 1 Baseline characteristics of women enrolled in SP in vivo efficacy study, Burkina-Faso and Mali

Age, years,

Mean (SD)

23.6 (5.4)

21.1 (5.1)

22.5 (5.4)

Residing in rural area, n (%)

81 (30.2)

146 (45.2)

222 (38.3)

Knows the date of LMP, n (%)

44 (16.4)

61 (19.6)

105 (18.1)

Pregnancy number

Median (range)

2 (1–8)

2 (1–9)

2 (1–9)

First or second pregnancy, n (%)

204 (65.4)

185 (69.0)

389 (67.1)

Use of a bed net last night^a

Any net, n (%)

187 (60.1)

207 (77.2)

394 (68.1)

ITN, n (%)

171 (55.0)

180 (67.2)

351 (60.6)

Use medicine in first trimester

Any medicine, n (%)

6 (1.9)

25 (9.3)

31(5.3)

Antimalarial, n (%)

2 (0.6)

15 (5.6)

17 (2.9)

Fundal height, cm

Mean (SD)

21.5 (2.9)

21.8 (3.2)

21.7 (3.1)

Gestational age, weeks

Mean (SD)

25.3 (3.1)

25.4 (3.2)

25.3 (3.1)

Maternal height, cm

Mean (SD)

162.7 (6.2)

162.2 (6.3)

162.4 (6.2)

Maternal weight, kgs

Mean (SD)

57.8 (7.5)

56.4 (8.5)

57.2 (8.0)

Haemoglobin, g/dL^b

Mean (SD)

10.1 (1.4)

9.6 (1.6)

9.9 (1.5)

Anaemia (Hb <11 /dL), n (%)

225 (72.4)

198 (80.5)

423 (75.9)

Moderate-Severe anaemia (Hb <8g/dL),

22 (7.1)

40 (16.3)

62 (11.1)

n (%)

Peripheral parasitaemia

623

716

664

GMPD/μl (95% CI)

(537–723)

(598–859)

(592–746)